{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:57:48Z","timestamp":1791608268516,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":5372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1006\/viro.1998.9367","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T14:46:43Z","timestamp":1034002003000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":224,"title":["Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates"],"prefix":"10.1006","volume":"251","author":[{"given":"Michael","family":"Hevey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Negley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pushko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Schmaljohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/viro.1998.9367_VY989367RF1","first-page":"32","article-title":"Survival of Marburg virus infectivity on contaminated surfaces and in aerosols","volume":"41","author":"Belanov","year":"1996","journal-title":"Vopr. Virusol."},{"key":"10.1006\/viro.1998.9367_VY989367RF2","doi-asserted-by":"crossref","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","author":"Bray","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1006\/viro.1998.9367_VY989367RF3","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/jvi.71.4.3031-3038.1997","article-title":"Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector","volume":"71","author":"Caley","year":"1997","journal-title":"J. Virol."},{"key":"10.1006\/viro.1998.9367_VY989367RF4","article-title":"Pathogenesis of experimental Ebola virus infection in guinea pigs","author":"Connolly","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1006\/viro.1998.9367_VY989367RF5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)60733-2","article-title":"Marburg and Ebola viruses","volume":"47","author":"Feldmann","year":"1996","journal-title":"Adv. Virus Res."},{"key":"10.1006\/viro.1998.9367_VY989367RF6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/viro.1994.1147","article-title":"Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein","volume":"199","author":"Feldmann","year":"1994","journal-title":"Virology"},{"key":"10.1006\/viro.1998.9367_VY989367RF7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0042-6822(91)90680-A","article-title":"Glycosylation and oligomerization of the spike protein of Marburg virus","volume":"182","author":"Feldmann","year":"1991","journal-title":"Virology"},{"key":"10.1006\/viro.1998.9367_VY989367RF8","first-page":"275","article-title":"Stability of Marburg virus to lyophilization process and subsequent storage at different temperatures","volume":"41","author":"Frolov","year":"1996","journal-title":"Vopr. Virusol."},{"key":"10.1006\/viro.1998.9367_VY989367RF9","series-title":"Vaccines 97","article-title":"Assessment of protective immunity conferred by recombinant vaccinia viruses to guinea pigs challenged with ebola virus","author":"Gilligan","year":"1997"},{"key":"10.1006\/viro.1998.9367_VY989367RF10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/viro.1997.8883","article-title":"Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants","volume":"239","author":"Hevey","year":"1997","journal-title":"Virology"},{"key":"10.1006\/viro.1998.9367_VY989367RF11","first-page":"421","article-title":"A comparative study of the immunological indices in guinea pigs administered an inactivated Marburg virus","volume":"36","author":"Ignat'ev","year":"1991","journal-title":"Vopr. Virusol."},{"key":"10.1006\/viro.1998.9367_VY989367RF12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0168-1656(95)00104-2","article-title":"Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys","volume":"44","author":"Ignat'ev","year":"1996","journal-title":"J. Biotechnol."},{"key":"10.1006\/viro.1998.9367_VY989367RF13","first-page":"227","article-title":"Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus","volume":"76","author":"Johnson","year":"1995","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1006\/viro.1998.9367_VY989367RF14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(77)92000-1","article-title":"Isolation and partial characterization of a new virus causing acute hemorrhagic fever in Zaire","volume":"1","author":"Johnson","year":"1977","journal-title":"Lancet"},{"key":"10.1006\/viro.1998.9367_VY989367RF15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000149300","article-title":"Filoviridae: A taxonomic home for Marburg and Ebola viruses?","volume":"18","author":"Kiley","year":"1982","journal-title":"Intervirology"},{"key":"10.1006\/viro.1998.9367_VY989367RF16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(80)92352-1","article-title":"Inactivated vaccine for Ebola virus efficacious in guinea pig model [letter]","volume":"2","author":"Lupton","year":"1980","journal-title":"Lancet"},{"key":"10.1006\/viro.1998.9367_VY989367RF17","series-title":"Marburg Virus Disease.","author":"Martini","year":"1971"},{"key":"10.1006\/viro.1998.9367_VY989367RF18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(77)92002-5","article-title":"Isolation of Marburg-like virus from a case of hemorrhagic fever in Zaire","volume":"1","author":"Pattyn","year":"1977","journal-title":"Lancet"},{"key":"10.1006\/viro.1998.9367_VY989367RF19","series-title":"Vaccines 97","article-title":"Venezuelan equine encephalitis virus replicon vector: Immunogenicity studies with Ebola NP, and GP genes in guinea pigs","author":"Pushko","year":"1997"},{"key":"10.1006\/viro.1998.9367_VY989367RF20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"key":"10.1006\/viro.1998.9367_VY989367RF21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"Schmaljohn","year":"1982","journal-title":"Nature"},{"key":"10.1006\/viro.1998.9367_VY989367RF22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1006\/viro.1995.1019","article-title":"Isolation and initial characterization of a newfound hantavirus from California","volume":"206","author":"Schmaljohn","year":"1995","journal-title":"Virology"},{"key":"10.1006\/viro.1998.9367_VY989367RF23","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1006\/viro.1998.9367_VY989367RF24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(82)91871-2","article-title":"Marburg-virus disease in Kenya","volume":"1","author":"Smith","year":"1982","journal-title":"Lancet"},{"key":"10.1006\/viro.1998.9367_VY989367RF25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/viro.1998.9176","article-title":"DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge","volume":"246","author":"VanderZanden","year":"1998","journal-title":"Virology"},{"key":"10.1006\/viro.1998.9367_VY989367RF26","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","article-title":"Processing of the Ebola virus glycoprotein by the proprotein convertase furin","volume":"95","author":"Volchkov","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.1998.9367_VY989367RF27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm0198-037","article-title":"Immunization for Ebola virus infection","volume":"4","author":"Xu","year":"1998","journal-title":"Nat. Med."},{"key":"10.1006\/viro.1998.9367_VY989367RF28","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1073\/pnas.92.7.3009","article-title":"Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus","volume":"92","author":"Zhou","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682298993679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682298993679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:58:47Z","timestamp":1758581927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682298993679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["S0042682298993679"],"URL":"https:\/\/doi.org\/10.1006\/viro.1998.9367","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[1998,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/viro.1998.9367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}